Fovargue, Sara J. (2005) A Leap of Faith? Sanctioning Xenotransplant Clinical Trials. Liverpool Law Review, 26 (2). pp. 125-147.
Full text not available from this repository.Abstract
Introducing a new medical technique, procedure or drug to the public via clinical trials is risky at the best of times. When the trial involves a biotechnology which holds out the promise of prolonging, if not saving, life the push to move from the laboratory to clinical trials may be hard to resist. In this article I explore whether the regulatory scheme for clinical trials in the UK is able to accommodate developing technologies by considering how the current legal and ethical frameworks determine when a procedure such as xenotransplantation should proceed to trials. In particular, I discuss whether basing our regulatory schemes on the principles espoused in the Declaration of Helsinki offer sufficient protection to those who may be affected by xenotransplant trials – the recipient, their health-care workers, close contacts and, unusually, the wider public. I question whether it is possible for a technology to be approved for clinical trials when allowing such trials may benefit the individual but ultimately negatively impact on society as a whole.
| Item Type: | Article |
|---|---|
| Journal or Publication Title: | Liverpool Law Review |
| Uncontrolled Keywords: | clinical trials - organs - regulation - risk - therapeutic benefit - xenotransplantation |
| Subjects: | K Law > K Law (General) |
| Departments: | Faculty of Arts & Social Sciences > Law School |
| ID Code: | 20839 |
| Deposited By: | Dr Sara Fovargue |
| Deposited On: | 03 Dec 2008 13:12 |
| Refereed?: | Yes |
| Published?: | Published |
| Last Modified: | 26 Jul 2012 15:41 |
| Identification Number: | |
| URI: | http://eprints.lancs.ac.uk/id/eprint/20839 |
Actions (login required)
| View Item |
